New schemes

Labquality is planning to organise an EQA pilot study for Alzheimer’s disease biomarkers. In order to determine the level of interest for this program, we would appreciate your participation in our online survey.

Your response will provide valuable information for the development of our EQA programs.

Please send your response to the online survey by 15 March 2026.

Labquality is introducing a new scheme for Candida auris, nucleic acid detection. We are inviting a limited number of laboratories to participate in a pilot study of this new scheme free of charge. The scheme is suitable for clinical laboratories and point-of-care testing sites.

Registration is open until 15 March 2026.

Labquality is introducing a new scheme for Cryptosporidium/Giardia/Entamoeba, antigen detection. We are inviting a limited number of laboratories to participate in a pilot study of this new scheme free of charge. The scheme is suitable for clinical laboratories and point-of-care testing sites.

Registration is open until 15 March 2026.

Labquality is introducing a new scheme for HCV RNA, capillary blood, point-of-care test (POCT). We are inviting a limited number of testing sites to participate in a free pilot study for this new scheme. The scheme is primarily intended for point-of-care testing sites.

Registration is open until 15 March 2026.

Labquality is introducing a new scheme for preanalytics, focusing on extended specimen
collection. This pilot is free of charge, and it is intended for professionals involved in sample collection and/or clinical physiology activities listed below.

Registration is open until 15 March 2026.

Labquality is introducing a new product line for Next Generation Sequencing (NGS) for somatic tumours. We are inviting a limited number of laboratories to participate free of charge in a pilot study for this new scheme. The scheme is suitable for all NGS methods.

Registration for this pilot study is closed.